Suzlon Energy Q4 FY2026 Profit Declines 6 Despite Robust Revenue Surge Italys Top Court Rules No Legal Right to Free Tap Water in Hotels Setting Precedent for Hospitality Industry Inflation Pressures Persist Ahead of Memorial Day Weekend With Travel and Food Costs Rising Most Ponyai Assures Operations Unaffected by SelfDriving Car Safety Review SpaceX IPO Speculation Nvidia Earnings and Bezos AI Remarks Lead Morning Market Brief Eli Lillys Retatrutide Gains Attention Following CNBC Report on Phase 3 Data Danaher Q1 2026 Earnings Earnings Per Share Beats Estimates Amid Slight Stock Pullback ACT Q1 2026 Earnings EPS Beats Estimates by 239 Amid Stable Credit Trends Kenon Holdings Q2 2025 Earnings Modest Profit Amid Quiet Quarter ADAM Q1 2026 Earnings Strong EPS Beat Drives Optimism ENPH Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment Modiv Industrial Inc Class C MDV Q1 2026 Earnings Steep EPS Miss and Stock Decline Highlight Challenging Quarter XOMA Royalty Preferred Stock XOMAP Holds Steady Near 2545 Amid Low Volatility ProKidney Corp PROK Jumps Over 7 as Biotech Stock Tests Resistance at 190 ATIF Holdings ZBAI Holds Flat at 895 as Traders Assess Key Levels DMII Drugs Made In America Acquisition II Corp Hovers Near Resistance as Trading Volume Remains Subdued TWLV Stock Holds Steady at 995 as Investors Eye Support and Resistance Levels Home Depot Comparable Sales Catch Up to Lowes Potentially Signaling Stock Performance Shift RIOT Q1 2026 Earnings EPS Lags Consensus by Wide Margin Stock Climbs 037 Despite Miss Eagle Materials Inc EXP Holds Steady Near 200 Resistance in Sight NU Q1 2026 Earnings EPS Misses Estimates Amid Strong Operational Momentum Ross Stores ROST Q1 2026 Earnings EPS Surges Past Estimates Despite Muted Revenue Disclosure Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment FUBO Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher SAT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Quarter OSBC Q1 2026 Earnings Earnings Miss but Stable Share Price RZLT Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Pipeline Advances